Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Cordis Protection From Pulmonary Embolism With the Permanent OptEase™ Filter - A Post Marketing Surveillance Study (PROOF Study)

NCT00233740 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT00233740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Cordis Protection From Pulmonary Embolism With the Permanent OptEase™ Filter - A Post Marketing Surveillance Study (PROOF Study)
Lead sponsor
Cordis US Corp.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2003
Completion date
May 31, 2005
Enrollment
150
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism